top of page
News
Fresenius Kabi and Lupagen enter into strategic development and supply agreement to bring cell and gene therapies to the bedside
August 24, 2023
Potent In Vivo CAR T Cell Generation and Durable Antitumor Activity in Preclinical Models Using VivoVec, a Surface-Engineered Lentiviral Vector Drug Product
American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
May 16, 2023
Umoja Biopharma and Lupagen Announce New Collaboration to Improve Patient Experience and Access to Next-Generation In Vivo Therapeutics for Cancer
May 23, 2022
bottom of page
